当前位置: 首页 > 详情页

Exploring the Diagnostic Biomarkers of Cognitive Disorders in China

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Xuan Wu Hospital of Capital Medical University, Beijing, China, 100053 [2]First Hospital of Shijiazhuang City [3]Chongqing Medical University [4]Tianjin Huanhu Hospital [5]Central hospital Affiliated to Shandong First Medical University

关键词: dementia diagnostic biomarkers

研究目的:
Dementia is a syndrome characterized by progressive global cognitive impairment that impairs occupational, family, or social functioning. It detrimentally affects personal health and quality of life, imposing significant medical economy, social and psychological burden on the countries and the patients' family. The internationally renowned dementia cohort includes the DIAN that focused on genetics studies, the ADNI cohort featuring imaging and the FINGERS cohort focused on risk factor intervention, etc. Establishing standardized and shared longitudinal follow-up dementia cohorts and clinical database is an essential challenge for constructing dementia cohort in China. Moreover, there is a lack of large-scale prospective longitudinal follow-up cohorts within the Chinese population that cover subjective cognitive decline (SCD) to explore biomarkers with diagnostic and early warning value for different kinds of dementia and pre-dementia stages. The study will rely on the dementia cohort based on Chinese population to explore the biological phenotype characteristics of the pre-dementia stage and different dementia subtypes, and observe the dynamic change rules of the dementia cohort vertically, so as to foster early intervention and improve prognosis for individuals with dementia.

资源点击量:17919 今日访问量:0 总访问量:968 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院